Lincoln Muir

Title: Innovations in Cancer Cell Monitoring by Inventor Lincoln Muir

Introduction

Lincoln Muir, an innovative inventor based in San Diego, CA, has made significant contributions to cancer research through his patent involving cell-substrate impedance monitoring of cancer cells. With a focus on enhancing the understanding of cytolysis in cancer treatments, Muir's work is a pivotal advancement in the field of oncology.

Latest Patents

Muir holds a patent for a method titled "Cell-substrate impedance monitoring of cancer cells." This innovative approach provides a series of methods aimed at assessing the effectiveness of immune cells targeting cancer cells. Key steps in this patent include utilizing a cell-substrate impedance monitoring device connected to an impedance analyzer, adding cancer cells and effector immune cells from the same patient, monitoring changes in cell-substrate impedance, and determining the effectiveness of the effector cells by comparing impedance data. This patent identifies a novel technique that can aid in assessing the interactions between cancer cells and immune responses in real-time.

Career Highlights

Lincoln Muir is currently associated with Agilent Technologies, Inc., a reputable company known for its contributions to life sciences and diagnostic applications. His work here emphasizes his dedication to leveraging technology in pursuit of more effective cancer therapies.

Collaborations

Muir collaborates with esteemed colleagues Xiaobo Wang and Yama A Abassi, forming a team committed to advancing cancer research and exploring innovative methodologies for treating this complex disease. Their combined expertise plays a crucial role in bolstering research efforts and developing effective solutions for cancer treatment.

Conclusion

Lincoln Muir's inventive spirit and dedication to medical innovation, particularly in the realm of cancer cell monitoring, demonstrate his significant role in the ongoing battle against cancer. His patent signifies a marked improvement in understanding how immune cells interact with cancer cells, potentially leading to more effective therapies for patients in the future. As he continues to work with talented colleagues at Agilent Technologies, Muir’s contributions to science and medicine are set to leave a lasting impact on the field of oncology.